Dibenz(b,f)azepine → 9-[(2,4-Diaminoquinazolin-6-yl)methyl]dibenz[b,f]azepine
Reaction equation
NC1N=C(N)C2C(=NC=C(CN(C3C=CC=CC=3)C3C=CC=CC=3)N=2)N=1.[CH:27]1[C:37]2[CH:36]=[CH:35][C:34]3[CH:38]=[CH:39][CH:40]=[CH:41][C:33]=3[NH:32][C:31]=2[CH:30]=[CH:29][CH:28]=1.[H-].[Na+].Br.[NH2:45][C:46]1[N:55]=[C:54]([NH2:56])[C:53]2[C:48](=[CH:49][CH:50]=[C:51]([CH2:57]Br)[CH:52]=2)[N:47]=1>>[NH2:45][C:46]1[N:55]=[C:54]([NH2:56])[C:53]2[C:48](=[CH:49][CH:50]=[C:51]([CH2:57][C:38]3[C:34]4[CH:35]=[CH:36][C:37]5[CH:27]=[CH:28][CH:29]=[CH:30][C:31]=5[NH:32][C:33]=4[CH:41]=[CH:40][CH:39]=3)[CH:52]=2)[N:47]=1Participants
5
Procedure
9-[(2,4-Diaminoquinazolin-6-yl)methyl]dibenz[b,f]azepine (Formula I: Ar=2,4-diaminoquinazolin-6-yl; W=CH2; X=N; Z=CH═CH; m=n=0) is prepared similarly to N-[(2,4-diaminopteridin-6-yl)methyl]-N,N-diphenylamine as disclosed above by using dibenz[b,f]azepine (154 mg, 0.8 mmol), NaH (50 mg, 2.1 mmol), and 2,4-diamino-6-bromomethylquinazoline hydrobromide (100 mg, 0.3 mmol). The product can be purified by chromatography.
Workup
- customThe product can be purified by chromatography
Sources & evidence
- ORD record
- ord-188d2acb12954dfbbfb32e278400d0df
- Source dataset
- uspto-grants-2006_06
- Patent number
- US07056911B1
Reaction notes
Loading…